HLS Therapeutics Inc. (OTCMKTS:HLTRF – Get Free Report)’s share price traded up 1.6% during mid-day trading on Thursday . The company traded as high as $2.54 and last traded at $2.54. 1,700 shares were traded during trading, a decline of 62% from the average session volume of 4,473 shares. The stock had previously closed at $2.50.
HLS Therapeutics Trading Up 1.6 %
The business has a 50-day simple moving average of $2.53 and a 200-day simple moving average of $2.67.
About HLS Therapeutics
HLS Therapeutics Inc, a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease.
See Also
- Five stocks we like better than HLS Therapeutics
- What is Short Interest? How to Use It
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- Why Invest in 5G? How to Invest in 5G Stocks
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Following Congress Stock Trades
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for HLS Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HLS Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
